XAIR Beyond Air, Inc. - Common Stock
NASDAQ · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 13, 2026
$2,82
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$2,3852tyg. minimum
$55,6052tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$2M
P/E (TTM)
-0.2
EPS (TTM)
$-13.48
Przychody (TTM)
$8M
Twoje odznaki
Zakres 52 tyg.
$2–$56
Ocena Analityków
BUY
Cena Docelowa
$20
P/E
-0.2
ROE
-561.8%
Marża Zysku Netto
-435.7%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
XAIR Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$2.82
Kapitalizacja Rynkowa (MRQ)
$2M
P/E (TTM)
-0.2
EPS (TTM)
$-13.48
Przychody (TTM)
$8M
ROE (TTM)
-561.8%
Zakres 52 tyg.
$2–$56
XAIR Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Podziały akcji
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 13 lipca 2026 | 1-for-20 | Odwrotny |
| 14 lipca 2025 | 1-for-20 | Odwrotny |
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$8M2019-03-31 → 2026-03-31
EPS$-4.012017-12-31 → 2026-03-31
Wolny przepływ pieniężny$-19M2019-03-31 → 2026-03-31
Marża netto-435.7%2017-12-31 → 2026-03-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | XAIR | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -0.2średnia z 5 lat ≈-24.9 | ≈-24.9 | · | · | |
| P/S (TTM) | 0.3średnia z 5 lat ≈1861.7 | ≈1861.7 | 2.4 | Niedowartościowany | |
| P/B (MRQ) | 1.0średnia z 5 lat ≈52.5 | ≈52.5 | 0.3 | Niedowartościowany | |
| Cena / FCF (TTM) | -0.1średnia z 5 lat ≈-62.4 | ≈-62.4 | · | · | |
| Cena / Przepływy pieniężne (TTM) | -0.1średnia z 5 lat ≈-67.8 | ≈-67.8 | · | · | |
| Price / Tangible Book (Cena / Wartość księgowa materialna) | 0.3średnia z 5 lat ≈55.3 | ≈55.3 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | XAIR | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 4.2%średnia z 5 lat ≈-51.5% | ≈-51.5% | · | · | |
| Marża Operacyjna (TTM) | -364.8%średnia z 5 lat ≈-2338.8% | ≈-2338.8% | -267.5% | Poniżej średniej | |
| EBITDA Margin (Marża EBITDA) | -378.2%średnia z 5 lat ≈-2338.8% | ≈-2338.8% | -267.5% | Poniżej średniej | |
| Marża przed opodatkowaniem (TTM) | -447.6%średnia z 5 lat ≈-2434.4% | ≈-2434.4% | -245.2% | Słaby | |
| Marża Zysku Netto (TTM) | -435.7%średnia z 5 lat ≈-2296.4% | ≈-2296.4% | -118.9% | Słaby | |
| ROA (TTM) | -109.8%średnia z 5 lat ≈-86.6% | ≈-86.6% | -99.4% | Słaby | |
| ROE (TTM) | -561.8%średnia z 5 lat ≈-190.5% | ≈-190.5% | -169.3% | Słaby |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | XAIR | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 3.3średnia z 5 lat ≈4.5 | ≈4.5 | 1.4 | Silna płynność | |
| Wskaźnik Szybkości (MRQ) | 1.6średnia z 5 lat ≈3.3 | ≈3.3 | 1.0 | Silna płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | XAIR | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 107.3% | · | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 9.9% | · | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 54.5% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | XAIR | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.2średnia z 5 lat ≈0.1 | ≈0.1 | 0.2 | Zgodnie z | |
| Inventory Turnover (Rotacja zapasów) | 3.9średnia z 5 lat ≈2.1 | ≈2.1 | 1.1 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 8.6średnia z 5 lat ≈7.7 | ≈7.7 | 6.4 | Najwyższa półka | |
| Revenue / Employee (Przychody / pracownika) | ≈$142.2K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Wskaźnik przekroczeń
50.0%
Średnie zaskoczenie
-4.5%
Następny raport
Lis 09, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 31 marca 2027 | Sie 13, 2026 | $-11.00 | $-11.02 | 0.15% |
| 31 grudnia 2026 | Cze 15, 2026 | $-12.60 | $-11.56 | -9.0% |
| 30 czerwca 2026 | Sie 13, 2026 | $-10.79 | $-11.22 | 3.8% |
| 31 marca 2026 | $-12.60 | $-11.56 | -9.0% | |
| 31 grudnia 2025 | $-16.60 | $-16.68 | 0.46% | |
| 30 września 2025 | $-25.00 | $-17.44 | -43.3% | |
| 30 czerwca 2025 | $-30.60 | $-28.56 | -7.1% | |
| 31 marca 2025 | $-36.00 | $-49.78 | 27.7% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8M | $4M | $1M | · | · | $873.0K | $1M | $8M | |
| Cost of Revenue | $7M | $5M | $2M | $555.0K | · | · | · | · | |
| Gross Profit | $252.0K | $-2M | $-1M | $-555.0K | · | · | · | · | |
| R&D Expense | $10M | $17M | $24M | $17M | $12M | $13M | $11M | $4M | |
| SG&A Expense | $19M | $26M | $37M | $35M | $18M | $10M | $9M | $7M | |
| Operating Expenses | $29M | $43M | $62M | $52M | $41M | · | · | · | |
| Operating Income | $-29M | $-45M | $-63M | $-52M | $-41M | $-22M | $-18M | $-3M | |
| Interest Expense | · | · | $3M | $30.0K | $775.0K | $642.0K | $30.5K | $1.5K | |
| Interest Income | $303.0K | $705.0K | · | · | · | · | · | · | |
| Other Non-op | $-14.0K | $9.0K | $-169.0K | $-7M | $-3M | $-661.0K | $-2M | $-3.0K | |
| Pretax Income | $-34M | $-48M | $-64M | $-59M | $-44M | $-23M | $-20M | $-7M | |
| Income Tax | · | · | · | · | · | · | $-154.3K | · | |
| Net Income | $-33M | $-47M | $-60M | $-56M | $-43M | $-23M | $-20M | $-7M | |
| EPS (Basic) | $-4.01 | $-13.77 | $-1.82 | $-1.86 | $-1.68 | $-1.27 | · | $-0.77 | |
| EPS (Diluted) | $-4.01 | $-13.77 | $-1.82 | $-1.86 | · | · | · | $-0.77 | |
| Shares (Basic) | 8,300,916 | 3,385,327 | 33,160,180 | 29,973,639 | 25,668,230 | 18,005,226,000 | · | 8,498,525 | |
| Shares (Diluted) | 8,300,916 | 3,385,327 | 33,160,180 | 29,973,639 | · | · | · | 8,498,525 | |
| EBITDA | $-29M | $-45M | $-63M | $-52M | $-40M | · | $-18M | $-3M |
Bilans
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $5M | $11M | $29M | $80M | $35M | $20M | $1M | |
| Short-term Investments | $5M | $2M | $23M | $17M | · | · | · | $7M | |
| Receivables | $1M | $710.0K | $319.0K | · | $322.0K | $425.0K | · | · | |
| Inventory | $1M | $2M | $2M | $1M | $350.0K | · | · | · | |
| Prepaid Expense | $5M | $6M | $7M | $4M | $2M | $2M | $1M | $788.4K | |
| Other Current Assets | $190.0K | $203.0K | · | · | · | · | · | · | |
| Current Assets | $25M | $16M | $44M | $59M | $93M | $37M | $27M | $9M | |
| PP&E (Net) | $8M | $11M | $9M | $5M | $2M | $929.0K | $211.3K | $244.9K | |
| PP&E (Gross) | $16M | $17M | $12M | $6M | $3M | $1M | $491.0K | $447.4K | |
| Accum. Depreciation | $8M | $6M | $3M | $1M | $767.0K | $453.0K | $279.7K | $202.5K | |
| Intangibles | $1M | $1M | $1M | $2M | $2M | $346.0K | · | · | |
| Other Non-current Assets | $158.0K | $103.0K | $113.0K | $212.0K | $207.0K | $138.0K | · | · | |
| Total Assets | $35M | $30M | $57M | $69M | $99M | $41M | $27M | $9M | |
| Accounts Payable | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | |
| Accrued Liabilities | · | · | · | $17M | $8M | $2M | $1M | $2M | |
| Current Liabilities | $7M | $5M | $12M | $20M | $11M | $4M | $5M | $5M | |
| Capital Leases | $1M | $1M | $2M | $2M | $2M | $2M | $131.6K | · | |
| Other Non-current Liabilities | · | · | · | $4M | · | · | · | · | |
| Total Liabilities | $29M | $16M | $30M | $27M | $21M | $10M | $9M | $5M | |
| Long-term Debt | · | · | $18M | $200.0K | $200.0K | $4M | · | · | |
| Common Stock | · | · | $5.0K | $3.0K | $3.0K | $2.0K | $1.6K | $871 | |
| Paid-in Capital | $326M | $300M | $265M | $217M | $196M | $111M | $76M | $42M | |
| Retained Earnings | $-320M | $-286M | $-240M | $-179M | $-124M | $-80M | $-58M | $-38M | |
| Treasury Stock | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | |
| AOCI | $134.0K | $-60.0K | $-15.0K | $53.0K | $96.0K | · | · | · | |
| Stockholders' Equity | $6M | $14M | $25M | $38M | $73M | $30M | $18M | $4M | |
| Liabilities + Equity | $35M | $30M | $57M | $69M | $99M | $41M | $27M | $9M | |
| Shares Outstanding | 589,639 | 4,128,539 | 45,900,821 | 30,738,585 | 29,886,173 | 21,828,244 | 16,056,360 | 8,714,815 |
Przepływy pieniężne
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $2M | $600.0K | $314.0K | $173.0K | $77.2K | $64.8K | |
| Stock-based Comp | $5M | $9M | $21M | $20M | $8M | $5M | $4M | $2M | |
| Amort. of Intangibles | $204.0K | $205.0K | $205.0K | $205.0K | $38.0K | · | · | · | |
| Other Non-cash | · | · | · | · | $12M | · | $955.4K | $5M | |
| Operating Cash Flow | $-18M | $-38M | $-56M | $-33M | $-23M | $-20M | $-15M | $1M | |
| CapEx | $1M | $6M | $6M | $4M | $1M | $890.0K | $43.6K | $56.5K | |
| Investing Cash Flow | $-4M | $15M | $-12M | $-21M | $-1M | $-890.0K | $4M | $-2M | |
| Stock Issued | $4M | $19M | · | · | $25M | · | · | $799.2K | |
| Net Stock Activity | $4M | $19M | · | · | $25M | · | · | $799.2K | |
| Financing Cash Flow | $29M | $17M | $43M | $3M | $79M | $30M | $35M | $1M | |
| Net Change in Cash | $7M | $-7M | $-25M | $-51M | $55M | $10M | $24M | $618.9K | |
| Free Cash Flow | $-19M | $-44M | $-62M | $-37M | $-25M | · | $-15M | $1M | |
| Levered FCF | · | · | · | · | · | · | $-15M | · |
Rentowność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.3% | -44.9% | -112.8% | · | · | · | · | · | |
| Operating Margin | -378.2% | -1202.1% | -5436.2% | · | · | · | -1305.1% | -39.6% | |
| Net Margin | -433.0% | -1258.4% | -5197.8% | · | · | · | -1434.6% | -84.9% | |
| Pretax Margin | -447.1% | -1308.5% | -5547.4% | · | · | · | -1445.7% | · | |
| EBITDA Margin | -378.2% | -1202.1% | -5436.2% | · | · | · | -1293.6% | -38.8% | |
| ROA | -101.6% | -107.2% | -95.8% | -66.5% | -61.8% | · | -108.2% | -69.8% | |
| ROE | -337.4% | -241.4% | -191.4% | -100.9% | -81.3% | · | -132.5% | -202.4% | |
| ROIC | · | · | · | · | · | · | -101.0% | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 3.2 | 3.8 | 3.0 | 8.7 | · | 5.5 | 1.6 | |
| Quick Ratio | 2.0 | 1.5 | 3.0 | 2.3 | 7.5 | · | 4.1 | 1.5 | |
| Interest Coverage | · | · | -21.6 | -1735.3 | -52.5 | · | -594.0 | · |
Efektywność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | 0.0 | · | · | · | 0.1 | 0.8 | |
| Inventory Turnover | 3.9 | 2.4 | 1.5 | 0.8 | · | · | · | · | |
| Receivables Turnover | 8.6 | 7.2 | 7.3 | · | · | · | · | · |
Na akcję
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.52 | $0.16 | $0.55 | $1.23 | $2.43 | · | $1.13 | $0.46 | |
| Revenue / Share | $0.93 | $0.05 | $0.04 | · | · | · | · | $0.91 | |
| Cash Flow / Share | $-2.19 | $-0.56 | $-1.69 | · | · | · | · | $0.16 | |
| Cash / Share | $0.57 | $0.06 | $0.25 | $0.95 | $2.69 | · | $1.24 | $0.15 | |
| EPS (TTM) | $-4.01 | $-0.69 | $-1.82 | $-1.86 | · | · | · | $-0.77 |
Stopy Wzrostu
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 107.3% | 219.7% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | · | 9.9% | · | · | · | · | · | |
| Revenue CAGR 5Y | 54.5% | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $4M | $1M | $1M | $1M | $873.0K | $1M | $8M | |
| Net Income TTM | $-33M | $-47M | $-60M | $-56M | $-43M | $-23M | $-20M | $-7M | |
| Market Cap | $8M | $451M | $1.60B | $4.15B | $3.99B | · | $2.57B | $837M | |
| P/E | -0.2 | -7.9 | -19.1 | -72.6 | · | · | · | -124.7 | |
| P/S | 1.1 | 121.7 | 1378.2 | 3980.4 | 3827.3 | · | 1848.1 | 108.3 | |
| P/B | 1.3 | 33.2 | 63.8 | 109.4 | 54.9 | · | 142.0 | 207.9 | |
| P / Tangible Book | 1.6 | 36.5 | 67.6 | 114.4 | 56.3 | 79.7 | · | · | |
| P / Cash Flow | -0.4 | -11.8 | -28.5 | -125.7 | -172.5 | · | -168.5 | 623.9 | |
| P / FCF | -0.4 | -10.2 | -25.9 | -112.5 | -162.8 | · | -168.0 | 651.3 | |
| Earnings Yield | -581.2% | -12.6% | -5.2% | -1.4% | · | · | · | -0.80% |
Rachunek zysków i strat
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $798.0K | $683.0K | $470.0K | $391.0K | $239.0K | $59.0K | · | · | · | |
| Cost of Revenue | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | $983.0K | $748.0K | $432.0K | $303.0K | $308.0K | $68.0K | $179.0K | |
| Gross Profit | $225.0K | $94.0K | $300.0K | $-298.0K | $156.0K | $-32.0K | $-215.0K | $-1M | $-332.0K | $-514.0K | $-356.0K | $-193.0K | $-244.0K | $-308.0K | $-68.0K | $-179.0K | |
| R&D Expense | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $5M | $6M | $6M | $7M | $7M | $5M | $4M | $5M | $4M | |
| SG&A Expense | $5M | $5M | $4M | $5M | $5M | $4M | $8M | $7M | $7M | $6M | $10M | $10M | $11M | $10M | $9M | $8M | |
| Operating Expenses | $7M | $7M | $7M | $7M | $8M | $7M | $11M | $12M | $13M | $12M | $17M | $17M | $16M | $14M | $14M | $12M | |
| Operating Income | $-7M | $-7M | $-7M | $-8M | $-8M | $-7M | $-11M | $-13M | $-14M | $-13M | $-17M | $-18M | $-16M | $-14M | $-14M | $-13M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $919.0K | $914.0K | $158.0K | $-112.0K | $46.0K | $48.0K | |
| Interest Income | $103.0K | $114.0K | $102.0K | $59.0K | $28.0K | $68.0K | $126.0K | $150.0K | $361.0K | · | · | · | · | · | · | · | |
| Other Non-op | $-2M | $6.0K | $-162.0K | $48.0K | $-461.0K | $-1.0K | $-37.0K | $49.0K | $-2.0K | $-127.0K | $35.0K | · | $-77.0K | $-7M | $-52.0K | $88.0K | |
| Pretax Income | $-8M | $-10M | $-8M | $-8M | $-8M | $-8M | $-13M | $-14M | $-13M | $-15M | $-17M | $-17M | $-15M | · | · | · | |
| Net Income | $-8M | $-10M | $-7M | $-8M | $-8M | $-8M | $-13M | $-13M | $-12M | $-14M | $-16M | $-16M | $-14M | $-20M | $-13M | $-12M | |
| EPS (Basic) | $-11.00 | $-0.38 | $-0.85 | $-1.25 | $-30.67 | $0.18 | $-2.96 | $-5.67 | $-5.32 | $-0.36 | $-0.50 | $-0.51 | $-0.45 | $-0.66 | $-0.43 | $-0.40 | |
| EPS (Diluted) | $-11.00 | $-0.38 | $-0.85 | $-1.25 | $-30.67 | $0.18 | $-2.96 | $-5.67 | $-5.32 | $-0.36 | $-0.50 | $-0.51 | $-0.45 | $-0.66 | $-0.43 | $-0.40 | |
| Shares (Basic) | 721,328 | · | 8,616,860 | 6,356,573 | 250,747 | · | 4,403,726 | 2,355,927 | 2,295,042 | · | 32,462,476 | 31,800,492 | 31,382,986 | · | 29,921,254 | 29,898,825 | |
| Shares (Diluted) | 721,328 | · | 8,616,860 | 6,356,573 | 250,747 | · | 4,403,726 | 2,355,927 | 2,295,042 | · | 32,462,476 | 31,800,492 | 31,382,986 | · | 29,921,254 | 29,898,825 | |
| EBITDA | $-7M | · | $-7M | $-8M | $-8M | · | $-11M | $-13M | $-14M | · | $-17M | $-18M | $-16M | · | $-14M | $-13M |
Bilans
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $7M | $7M | $10M | $5M | $5M | $5M | $28M | $4M | $11M | $8M | $13M | $31M | $29M | $25M | $30M | |
| Short-term Investments | $4M | $5M | $5M | $996.0K | $1M | $2M | $6M | · | $17M | $23M | $23M | $25M | $26M | $17M | $28M | $33M | |
| Receivables | $1M | $1M | $1M | $892.0K | $804.0K | $710.0K | $639.0K | $556.0K | $475.0K | $319.0K | $294.0K | $205.0K | $44.0K | · | $355.0K | $235.0K | |
| Inventory | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $955.0K | $711.0K | |
| Prepaid Expense | $5M | $5M | $5M | $5M | $5M | $6M | $5M | $6M | $6M | $7M | $6M | $1M | $2M | $4M | $2M | $2M | |
| Other Current Assets | $206.0K | $190.0K | $122.0K | · | · | $203.0K | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $23M | $25M | $26M | $19M | $15M | $16M | $19M | $38M | $31M | $44M | $39M | $47M | $63M | $59M | $66M | $75M | |
| PP&E (Net) | $8M | $8M | $9M | $9M | $10M | $11M | $12M | $12M | $12M | $9M | $9M | $7M | $5M | $5M | $4M | $3M | |
| PP&E (Gross) | $16M | $16M | $15M | $16M | $16M | $17M | $17M | $16M | $16M | $12M | $11M | $9M | $7M | $6M | $5M | $4M | |
| Accum. Depreciation | $8M | $8M | $7M | $7M | $6M | $6M | $5M | $4M | $4M | $3M | $2M | $2M | $2M | $1M | $1M | $855.0K | |
| Intangibles | · | $1M | · | · | · | $1M | · | · | · | · | $1M | $2M | $2M | · | · | · | |
| Other Non-current Assets | $94.0K | $158.0K | $175.0K | $306.0K | $112.0K | $103.0K | $100.0K | $105.0K | $112.0K | $113.0K | $213.0K | $224.0K | $226.0K | $212.0K | $211.0K | $205.0K | |
| Total Assets | $33M | $35M | $37M | $31M | $28M | $30M | $34M | $53M | $46M | $57M | $52M | $58M | $73M | $69M | $74M | $82M | |
| Accounts Payable | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $3M | $2M | $3M | $3M | $2M | $2M | $1M | $2M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | $8M | $8M | $9M | · | $10M | $9M | |
| Current Liabilities | $7M | $7M | $5M | $4M | $5M | $5M | $5M | $7M | $12M | $12M | $12M | $12M | $12M | $20M | $12M | $12M | |
| Capital Leases | $977.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Liabilities | · | · | · | $2M | $2M | · | · | · | · | · | · | · | $4M | $4M | · | · | |
| Total Liabilities | $30M | $29M | $28M | $18M | $18M | $16M | $16M | $24M | $29M | $30M | $28M | $29M | $34M | $27M | $19M | $18M | |
| Long-term Debt | · | · | · | · | · | · | $12M | $12M | $18M | · | $18M | $18M | $18M | · | · | · | |
| Common Stock | · | $1.0K | $1.0K | $1.0K | · | $8.0K | $7.0K | $7.0K | $5.0K | $5.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $329M | $326M | $317M | $315M | $304M | $300M | $296M | $293M | $268M | $265M | $247M | $235M | $229M | $217M | $210M | $205M | |
| Retained Earnings | $-328M | $-320M | $-309M | $-302M | $-294M | $-286M | $-278M | $-265M | $-252M | $-240M | $-226M | $-210M | $-194M | $-179M | $-159M | $-147M | |
| Treasury Stock | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | |
| AOCI | $113.0K | $134.0K | $110.0K | $85.0K | $67.0K | $-60.0K | $-51.0K | $9.0K | $88.0K | $-15.0K | $34.0K | $43.0K | $78.0K | $53.0K | $159.0K | $438.0K | |
| Stockholders' Equity | $2M | $6M | $8M | $13M | $10M | $14M | $18M | $28M | $16M | $25M | $21M | $26M | $35M | $38M | $51M | $59M | |
| Liabilities + Equity | $33M | $35M | $37M | $31M | $28M | $30M | $34M | $53M | $46M | $57M | $52M | $58M | $73M | $69M | $74M | $82M | |
| Shares Outstanding | 743,418 | 11,792,684 | 8,404,354 | 8,009,488 | 4,693,284 | 4,128,539 | 74,328,645 | 72,187,636 | 45,900,821 | 45,900,821 | 35,478,123 | 31,972,434 | 31,711,317 | 30,738,585 | 30,013,907 | 29,911,207 |
Przepływy pieniężne
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $800.0K | $700.0K | $800.0K | $800.0K | $800.0K | $700.0K | $800.0K | $800.0K | $700.0K | $691.0K | $400.0K | $400.0K | $309.0K | $179.0K | $200.0K | $100.0K | |
| Stock-based Comp | $1M | $427.0K | $2M | $2M | $2M | $159.0K | $2M | $3M | $3M | $2M | $6M | $6M | $6M | $4M | $6M | $5M | |
| Amort. of Intangibles | $51.0K | $51.0K | $51.0K | $51.0K | $51.0K | $51.0K | $52.0K | $51.0K | $51.0K | $51.0K | $52.0K | $50.0K | $52.0K | $51.0K | $52.0K | $33.0K | |
| Operating Cash Flow | $-5M | $-5M | $-4M | $-4M | $-5M | $-7M | $-8M | $-13M | $-10M | $-11M | $-14M | $-14M | $-17M | $-8M | $-9M | $-9M | |
| CapEx | $208.0K | $547.0K | $34.0K | $246.0K | $198.0K | $1M | $537.0K | $1M | $3M | $2M | $1M | $2M | $795.0K | $2M | $634.0K | $963.0K | |
| Investing Cash Flow | $461.0K | $-447.0K | $-4M | $240.0K | $576.0K | $3M | $-7M | $16M | $3M | $-2M | $853.0K | $-2M | $-10M | $9M | $4M | $-34M | |
| Debt Issued | · | · | · | · | · | · | · | $0 | $100.0K | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $100.0K | · | · | · | · | · | · | · | |
| Stock Issued | · | $4M | · | · | · | $0 | $0 | · | · | · | $-6M | $-6M | $6M | · | $0 | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $6M | · | · | · | |
| Financing Cash Flow | $3M | $5M | $11M | $9M | $4M | $4M | $-9M | $22M | $-264.0K | $16M | $5M | $469.0K | $22M | $3M | $-310.0K | $133.0K | |
| Net Change in Cash | $-1M | $-468.0K | $3M | $5M | $243.0K | $64.0K | $-24M | $24M | $-7M | $3M | $-8M | $-16M | $-5M | $4M | $-4M | $-43M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $23.0K | · | |
| Free Cash Flow | $-5M | · | · | · | $-5M | · | · | · | $-13M | · | · | · | $-18M | · | · | · |
Rentowność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 12.7% | · | 13.7% | -16.4% | 8.9% | · | -20.1% | -135.8% | -48.6% | · | -91.0% | -80.8% | -413.6% | · | · | · | |
| Operating Margin | -374.0% | · | -300.6% | -421.4% | -432.8% | · | -1021.6% | -1608.1% | -1988.3% | · | -4338.4% | -7336.8% | -26906.8% | · | · | · | |
| Net Margin | -448.8% | · | -334.4% | -436.7% | -437.0% | · | -1215.7% | -1673.9% | -1786.4% | · | -4148.3% | -6786.6% | -23889.8% | · | · | · | |
| Pretax Margin | -461.2% | · | -347.8% | -454.2% | -459.0% | · | -1243.8% | -1758.0% | -1911.4% | · | · | · | · | · | · | · | |
| EBITDA Margin | -374.0% | · | -300.6% | -421.4% | -432.8% | · | -1021.6% | -1608.1% | -1988.3% | · | -4338.4% | -7336.8% | -26906.8% | · | · | · | |
| ROA | -26.0% | · | -20.7% | -18.9% | -20.6% | · | -30.3% | -24.1% | -20.4% | · | -25.8% | -23.2% | -17.1% | · | -14.7% | -17.6% | |
| ROE | -133.1% | · | -57.0% | -38.9% | -59.0% | · | -67.8% | -49.6% | -47.3% | · | -45.2% | -38.4% | -27.8% | · | -18.8% | -24.0% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | · | 5.1 | 4.2 | 3.2 | · | 3.6 | 5.8 | 2.6 | · | 3.4 | 3.8 | 5.3 | · | 5.7 | 6.5 | |
| Quick Ratio | 1.6 | · | 2.6 | 2.6 | 1.6 | · | 2.1 | 4.4 | 1.9 | · | 2.7 | 3.1 | 4.7 | · | 4.6 | 5.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -18.5 | -19.2 | -100.5 | · | -304.6 | -262.9 |
Efektywność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | |
| Inventory Turnover | 0.8 | · | 0.9 | 0.9 | 0.7 | · | 0.7 | 0.9 | 0.5 | · | 0.6 | 0.4 | 0.3 | · | 0.1 | 0.5 | |
| Receivables Turnover | 1.8 | · | 2.5 | 2.5 | 2.8 | · | 2.3 | 2.1 | 2.6 | · | 1.2 | 1.1 | 0.2 | · | · | · |
Na akcję
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.69 | · | $0.97 | $1.59 | $2.12 | · | $0.24 | $0.39 | $0.35 | · | $0.59 | $0.81 | $1.12 | · | $1.70 | $1.97 | |
| Revenue / Share | $2.45 | · | $0.25 | $0.29 | $0.35 | · | $0.01 | $0.02 | $0.01 | · | $0.01 | $0.01 | $0.00 | · | · | · | |
| Cash Flow / Share | $-6.86 | · | · | · | $-0.90 | · | · | · | $-0.22 | · | · | · | $-0.55 | · | · | · | |
| Cash / Share | $7.41 | · | $0.79 | $1.21 | $1.06 | · | $0.06 | $0.39 | $0.09 | · | $0.22 | $0.41 | $0.99 | · | $0.85 | $1.00 | |
| EPS (TTM) | $-13.48 | · | $-32.59 | $-34.70 | $-39.12 | · | $-14.31 | $-11.85 | $-6.69 | · | $-2.12 | $-2.05 | $-1.94 | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | · | $7M | $6M | $5M | · | $3M | $2M | $2M | · | · | · | · | · | $873.0K | $873.0K | |
| Net Income TTM | $-33M | · | $-31M | $-37M | $-42M | · | $-52M | $-55M | $-58M | · | $-67M | $-63M | $-59M | · | $-56M | $-51M | |
| Market Cap | $331.6K | · | $6M | $19M | $16M | · | $534M | $560M | $493M | · | $1.39B | $1.48B | $2.70B | · | $3.90B | $4.45B | |
| P/E | -0.7 | · | -0.4 | -1.3 | -1.8 | · | -10.0 | -13.1 | -32.1 | · | -369.8 | -450.7 | -878.4 | · | · | · | |
| P/S | 0.9 | · | 17.6 | 63.8 | 67.5 | · | 3530.8 | 4783.7 | 5529.7 | · | · | · | · | · | 89251.0 | 101965.4 | |
| P/B | 0.2 | · | 0.8 | 1.5 | 1.6 | · | 30.2 | 19.9 | 30.6 | · | 66.8 | 57.4 | 76.2 | · | 76.5 | 75.7 | |
| P / Tangible Book | 0.2 | · | 0.8 | 1.5 | 1.6 | · | 30.2 | 19.9 | 30.6 | · | 71.9 | 61.0 | 79.8 | · | 76.5 | 75.7 | |
| P / Cash Flow | -0.1 | · | · | · | -3.6 | · | · | · | -48.4 | · | · | · | -157.5 | · | · | · | |
| Earnings Yield | -151.1% | · | -224.4% | -75.1% | -56.9% | · | -10.0% | -7.6% | -3.1% | · | -0.27% | -0.22% | -0.11% | · | · | · |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Przychody | $8M | $4M | $1M | · | · |
| Marża Brutto % | 3.3% | -44.9% | -112.8% | · | · |
| Marża Operacyjna % | -378.2% | -1202.1% | -5436.2% | · | · |
| Zysk netto | $-33M | $-47M | $-60M | $-56M | $-43M |
| Rozwodniony EPS | $-4.01 | $-13.77 | $-1.82 | $-1.86 | · |
| Wskaźnik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 3.8 | 3.2 | 3.8 | 3.0 | 8.7 |
| Wskaźnik Szybkości | 2.0 | 1.5 | 3.0 | 2.3 | 7.5 |
| Wskaźnik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-19M | $-44M | $-62M | $-37M | $-25M |
Właściciele instytucjonalni (13F) 32 emitenci · $836K łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
32
Wartość posiadanych akcji
$836K
Nowe pozycje
5
Zamknięte pozycje
5
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 5 (-1 vs poprzedni kw.) | 5 (+2 vs poprzedni kw.) | 2 (0 vs poprzedni kw.) | 6 (-3 vs poprzedni kw.) | -16K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Balyasny Asset Management L.P. | $206 969 | 464 161 | 24,75% | Akcje |
| LASRY MARC | $189 305 | 81 950 | 22,64% | Akcje |
| Murchinson Ltd. | $122 269 | 274 208 | 14,62% | Akcje |
| Daytona Street Capital LLC | $61 454 | 151 550 | 7,35% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $50 049 | 112 242 | 5,99% | Akcje |
| VANGUARD GROUP INC | $43 877 | 60 437 | 5,25% | Akcje |
| Bleichroeder LP | $38 565 | 86 489 | 4,61% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $27 982 | 62 741 | 3,35% | Akcje |
| COMMONWEALTH EQUITY SERVICES, LLC | $21 130 | 47 382 | 2,53% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $13 098 | 29 368 | 1,57% | Akcje |
| StoneX Group Inc. | $9 971 | 21 559 | 1,19% | Akcje |
| BlackRock, Inc. | $9 825 | 22 033 | 1,18% | Akcje |
| XTX Topco Ltd | $7 882 | 17 677 | 0,94% | Akcje |
| NORTHERN TRUST CORP | $7 601 | 17 046 | 0,91% | Akcje |
| WEALTH EFFECTS LLC | $7 565 | 16 965 | 0,90% | Akcje |
| BALDWIN WEALTH PARTNERS LLC/MA | $6 599 | 14 800 | 0,79% | Akcje |
| Kaye Capital Management | $4 514 | 26 200 | 0,54% | Akcje |
| OSAIC HOLDINGS, INC. | $3 649 | 8 116 | 0,44% | Akcje |
| Tower Research Capital LLC (TRC) | $2 043 | 4 582 | 0,24% | Akcje |
| PFS Partners, LLC | $892 | 2 000 | 0,11% | Akcje |
| IFP Advisors, Inc | $507 | 1 136 | 0,06% | Akcje |
| NewEdge Advisors, LLC | $204 | 457 | 0,02% | Akcje |
| GROUP ONE TRADING LLC | $60 | 135 | 0,01% | Akcje |
| GODSEY & GIBB, INC | $23 | 50 | 0,00% | Akcje |
| MORGAN STANLEY | $18 | 40 | 0,00% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $18 | 41 | 0,00% | Akcje |
| CWM, LLC | $17 | 25 | 0,00% | Akcje |
| JPMORGAN CHASE & CO | $15 | 32 | 0,00% | Akcje |
| FMR LLC | $11 | 25 | 0,00% | Akcje |
| HRT FINANCIAL LP | $9 | 21 097 | 0,00% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $5 | 10 | 0,00% | Akcje |
| UBS Group AG | $4 | 9 | 0,00% | Akcje |
Insiderzy spółki 17 insiderów · 10 dyrektorzy generalni · 10 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robert Scott Goodman | Chief Executive Officer | 29 lipca 2026 P | 34 822 | 1 | 0 | $199 999 |
| Steven A. Lisi | CEO and Chairman of the Board | 4 listopada 2025 A | 3 327 411 | 0 | 0 | $0 |
| Daniel J Moorhead | Chief Financial Officer | 29 lipca 2026 P | 4 340 | 1 | 0 | $24 998 |
| Douglas Quinton Larson | Chief Financial Officer | 4 listopada 2025 A | 27 548 | 0 | 0 | $0 |
| Douglas Beck | Chief Financial Officer | 16 czerwca 2021 P | 22 460 | 0 | 0 | $0 |
| Haim Aviv | Chief Financial Officer | 15 maja 2017 A | · | 0 | 0 | $0 |
| Michael A. Gaul | Chief Operating Officer | 4 listopada 2025 A | 94 150 | 0 | 0 | $0 |
| Amir Avniel | Chief Business Officer | 20 marca 2024 A | 0 | 0 | 0 | $0 |
| Jeff Lynn Myers | Chief Medical Officer | 27 grudnia 2023 S | 46 577 | 0 | 0 | $0 |
| David Grossman | Secretary | 16 lutego 2018 M | 4 008 | 0 | 0 | $0 |
| Yoori Lee | Dyrektor | 4 listopada 2025 A | 12 654 | 0 | 0 | $0 |
| Erick Lucera | Dyrektor | 4 listopada 2025 A | 43 608 | 0 | 0 | $0 |
| William P Forbes | Dyrektor | 4 listopada 2025 A | 14 855 | 0 | 0 | $0 |
| Robert Carey | Dyrektor | 3 listopada 2025 A | 4 076 864 | 0 | 0 | $0 |
| Ron Bentsur | Dyrektor | 22 listopada 2024 A | 144 736 | 0 | 0 | $0 |
| Ari Raved | Dyrektor | 22 czerwca 2018 S | 565 885 | 0 | 0 | $0 |
| Yi-Chien Lin | Posiadacz 10% | 1 października 2026 P | 145 393 | 3 | 0 | $56 590 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 1 fundusz ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 62 741 SH | 19 sierpnia 2026 | Dziennie |
XAIR Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 7 analityków
KUP
Średni cel
$20.00
+609,2%
2 28,6%
Mocne kupno
4 57,1%
Kup
1 14,3%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
2 analityków · 2026-09-29Średnia cel $20.00 +609,2%
← Poniżej wszystkich celów
Aktualna cena $2.82
Niski$10.00
Średnia$20.00
Wysoki$30.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 13, 2026